iPSC-based therapy for vasodegenerative vessels

induced pluripotent stem cells · University of Alabama at Birmingham

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iPSC-based therapy for vasodegenerative vessels, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy